Well if they wander off their existing reservation they could buy pretty much anyone except for the big pharma. So let's assume they stay in fields where they are currently a player or have an existing program.
1. HIV - hard to see anything happening here
2. HCV - ditto, unless they have some hidden need I don't know about
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.